|
National Stock Number(NSN): 6505-00-619-8885 (6505006198885, 006198885)
| NIIN: |
00-619-8885 |
Item Name: |
RESERPINE TABLETS |
INC: |
09587
|
| FSC: |
6505
|
Assignment Date: |
Jan-01-1963 |
CRIT: |
X |
IIG: |
09587 |
| ISC: |
5 |
Date Standardized: |
Feb-01-1975 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Aug-31-2022 |
PMIC: |
U |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
3004.90.9220 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
98 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
RAUSED |
78473
|
SQUIBB E R AND SONS INC WORLD HQ |
H |
5 |
9 |
4 |
75 |
3 |
B |
|
|
|
|
|
RESERP0ID |
93703
|
PHARMACIA & UPJOHN COMPANY |
H |
3 |
1 |
6 |
75 |
3 |
D |
|
|
|
|
|
SERPANRAY |
18991
|
PANRAY DIV ORMONT DRUG AND CHEMICAL CO INC |
H |
5 |
9 |
4 |
75 |
3 |
B |
|
|
|
|
|
SERPASIL |
04482
|
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV |
H |
5 |
1 |
4 |
75 |
3 |
D |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
1.000 MILLIGRAMS RESERPINE ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1000.000 TABLETS |
| CSGS |
ADMINISTRATION |
ORAL |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| G57V |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54|57 |
|